Xylem (XYL) is a buy with strong demand from water scarcity, infrastructure upgrades, PFAS treatment, and promising growth via Evoqua integration. See more here.

Cell biology articles from across Nature Portfolio Cell biology is the discipline of biological sciences that studies the structure, physiology, growth, reproduction and death of cells. Research ...

Molecular biology articles from across Nature Portfolio Atom RSS Feed Molecular Biology is the field of biology that studies the composition, structure and interactions of cellular molecules such ...

Water technology provider Xylem launched a new innovation center in its Chinese headquarters in Shanghai on Monday. [Photo provided to chinadaily.com.cn] Water technology provider Xylem has launched a ...

School of Biosciences Our courses cover the full breadth of biology, from molecular and cell biology, genetics, development, human physiology and pharmacology through to evolution, ecology, ...

Cell biology news. Read the latest research news on cell biology and see related videos.

See Xylem Inc. (XYL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Find out all the key statistics for Xylem Inc. (XYL), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Biology news and videos from research institutes around the world. Updated daily.